Case File
efta-01977447DOJ Data Set 10OtherEFTA01977447
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01977447
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey Epsteir[jeevacalion©gmail.com]
From:
McGraw, Thomas
Sent:
Mon 11/19/2012 3:21:09 PM
Subject: RE:
Jeffrey — Generally no.. but a couple qualifying remarks
The definition of a "....qualified payment..." requires a "...fixed rate..." -- which we have always
illustrated & seen appraised in the market for actual transactions as numerically fixed with a definitive
percentage of the principal preferred equity issued at par (non cumulative with a rolling four grace
period on preferred yield payments) . That said the definition of the term "...fixed rate..." could also
generally include preferred capital accounts or preferred stock which are reset periodically in
accordance with an objective market reference ...however I would note that such variability in the fixed
rate requirement would add uncertainty to a already complex transaction, with complex valuations &
diminish success on any audit inquiry.
One other remark , there is no "fixed rate" requirement and these special valuation Code Sections 2701-
2704 are not applicable if the junior equity positions are not gifted to "....the transferor's spouse, the
lineal descendant's of the transferor or transferor's spouse or the spouse of any descendant..."
IRS Circular 230 Disclosure:
JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S.
tax matters contained herein (including any attachments) is not intended or written to be used, and
cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated
with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of avoiding U.S.
tax-related penalties.
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Saturday, November 17, 2012 12:03 PM
To: McGraw, Thomas
Subject:
can the preferred carry a varaible coupon, in the estate freeze?
EFTA_R1_00463972
EFTA01977447
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to Lees [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00463973
EFTA01977448
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.